Rat mesangial cell hypertrophy in response to transforming growth factor-β1

Kidney International

Volumn 44, Issue 5, 1993, Pages 948-958

  Choi, Mary E ^a   Kim, Eung Gook ^a   Huang, Qi ^a   Ballermann, Barbara J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; EXTRACELLULAR MATRIX; GLOMERULOSCLEROSIS; MESANGIUM CELL; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT;

AMINO ACID SEQUENCE; ANIMAL; BASE SEQUENCE; CELL DIVISION; DNA, COMPLEMENTARY; GENE EXPRESSION REGULATION; GLOMERULAR MESANGIUM; HYPERTROPHY; LEUCINE; MOLECULAR PROBES; MOLECULAR SEQUENCE DATA; PROLINE; RATS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; THYMIDINE; TRANSFORMING GROWTH FACTOR BETA;

EID: 0027424626     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1993.336     Document Type: Article

References (47)

1. BRENNER BM: Nephron adaptation to renal injury or ablation. Am J Physiol 249:F324-F337, 1985
2. OLSON JL, HEPTINSTALL RH: Biology of disease: Nonimmunologic mechanisms of glomerular injury. Lab Invest 59:564-578, 1988
3. ZATZ R, DUNN BR, MEYER TW, ANDERSON S, RENNKE HG, BRENNER BM: Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 77:1925-1930, 1986
4. OLIVER J: Architecture of the Kidney in Chronic Bright's Disease. New York, Hoeber, 1939
5. CHRISTIANSEN JS, GAMMELGARD J, TRONIER B, SVENDSEN PA, PARVING H-H: Kidney function and size in diabetics before and during initial insulin treatment. Kidney Int 21:683-688, 1982
6. BROCHNER-MORTENSEN J, DITZEL J: Glomerular filtration rate and extracellular fluid volume in insulin-dependent patients with diabetes mellitus. Kidney Int 21:696-698, 1982
7. ANDERSON S, MEYER TW, RENNKE HG, BRENNER BM: Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 76:612-619, 1985
8. FOGO A, ICHIKAWA I: Evidence for the central role of glomerular growth promoters in the development of sclerosis. Semin Nephrol 9:329-342, 1989
9. OKUDA S, LANGUINO LR, RUOSLAHTI E, BORDER WA: Elevated expression of transforming growth factor-β and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix. J Clin Invest 86:453-462, 1990
10. COIMBRA T, WIGGINS R, NOH JW, MERRITT S, PHAN SH: Transforming growth factor-β production in anti-glomerular basement membrane disease in the rabbit. Am J Pathol 138:223-234, 1991
11. BORDER WA, OKUDA S, LANGUINO LR, SPORN MB, RUOSLAHTI E: Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1. Nature 346:371-374, 1990
12. YAMAMOTO T, NAKAMURA T, NOBLE N, RUOSLAHTI E, BORDER W: Expression of transforming growth factor β is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci USA 90:1814-1818, 1993
13. OKUDA S, NAKAMURA T, YAMAMOTO T, RUOSLAHTI E, BORDER WA: Dietary protein restriction rapidly reduces transforming growth factor β1 expression in experimental glomerulonephritis. Proc Natl Acad Sci USA 88:9765-9769, 1991
14. MILLER DA, PELTON RW, DERYNCK R, MOSES HL: Transforming growth factor-β: A family of growth regulatory peptides. Ann NY Acad Sci 593:208-217, 1990
15. GRAY AM, MASON AV: Requirement for activin A and transforming growth factor-β1 proregions in homodimer assembly. Science 247:1328-1330, 1990
16. SPORN MB, ROBERTS AB: TGF-β: Problems and prospects. Cell Regul 1:875-882, 1990
17. SATO Y, TSUBOI R, LYONS R, MOSES H, RIFKIN DB: Characterization of the activation of latent TGF-β by co-cultures of endothelial cells and pericytes or smooth muscle cells: A self-regulating system. J Cell Biol 111:757-763, 1990
18. LYONS RM, GENTRY LE, PURCHIO AF, MOSES HL: Mechanism of activation of latent recombinant transforming growth factor β1 by plasmin. J Cell Biol 110:1361-1367, 1990
19. SPORN MB, ROBERTS AB: The transforming growth factor-betas: Past, present, and future. Ann NY Acad Sci 593:1-6, 1990
20. KNABBE C, LIPPMAN ME, WAKEFIELD LM, FLANDERS KC, KASID A, DERYNCK R, DICKSON RB: Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells. Cell 48:417-428, 1987
21. LIN HY, WANG X-F, NG-EATON E, WEINBERG RA, LODISH HF: Expression cloning of the TGF-β Type II receptor, a functional transmembrane serine/threonine kinase. Cell 68:775-785, 1992
22. MAJESKY MW, VOLKHARD L, TWARDZIK DR, SCHWARTZ SM, REIDY MA; Production of transforming growth factor β1 during repair of arterial injury. J Clin Invest 88:904-910, 1991
23. 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sci USA 88:6642-6646, 1991
24. CZAJA MJ, WEINER FR, FLANDERS KC, GIAMBRONE M-A, WIND R, BIEMPICA L, ZERN MA: In vitro and in vivo association of transforming growth factor-β1 with hepatic fibrosis. J Cell Biol 108:2477-2482, 1989
25. KULOZIK M, HOGG A, LANKAT-BUTTGEREIT B, KRIEG T: Colocalization of transforming growth factor β2 with a 1(I) procollagen mRNA in tissue sections of patients with systemic sclerosis. J Clin Invest 86:917-922, 1990
26. BORDER W, RUOSLAHTI E: Transforming growth factor-β in disease: The dark side of tissue repair. J Clin Invest 90:1-7, 1992
27. IGNOTZ RA, MASSAGUE J: Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 261:4337-4345, 1986
28. MACKAY K, STRIKER LJ, STAUFFER JW, DOI T, AGODOA LY, STRIKER GE: Transforming growth factor-β. Murine glomerular receptors and responses of isolated glomerular cells. J Clin Invest 83:1160-1167, 1989
29. BORDER WA, OKUDA S, LANGUINO LR, RUOSLAHTI E: Transforming growth factor-β regulates production of proteoglycans by mesangial cells. Kidney Int 37:689-695, 1990
30. LAIHO M, SAKSELA O, KESKI-OJA J: Transforming growth factor-β induction of type-1 plasminogen activator inhibitor. J Biol Chem 262:17467-17474, 1987
31. EDWARDS DR, MURPHY G, REYNOLDS J, WHITHAM SE, DOCHERTY AJP, ANGEL P, HEATH JK: Transforming growth factor-β modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 6:1899-1904, 1987
32. CHEIFETZ S, ANDRES JL, MASSAGUE J: The transforming growth factor-β receptor III is a membrane proteoglycan. J Biol Chem 263:16984-16991, 1988
33. 3 pituitary cells that recognizes transforming growth factor-β, activin, and inhibin. J Biol Chem 263:17225-17228, 1988
34. O'GRADY P, LIU Q, SHIAN HUANG S, SAN HUANG J: Transforming growth factor β (TGF-β) type V receptor has a TGF-β-stimulated serine/threonine-specific autophosphorylation activity. J Biol Chem 267:21033-21037, 1992
35. O'GRADY P, HUANG SS, HUANG JS: Expression of a new type high molecular weight receptor (type V receptor) of transforming growth factor β in normal and transformed cells. Biochem Biophys Res Commun 179:378-385, 1991
36. LAIHO M, WEIS FMB, MASSAGUÉ J: Concomitant loss of transforming growth factor (TGF)-β receptor types I and II in TGF-β-resistant cell mutants implicates both receptor types in signal transduction. J Biol Chem 265:18518-18524, 1990
37. WRANA JL, ATTISANO L, CARCAMO J, ZENTELLA A, DOODY J, LAIHO M, WANG X-F, MASSAGUÉ J: TGF-β signals through a heteromeric protein kinase receptor complex. Cell 71:1003-1014, 1992
38. SANGER F, NICKLEN S, COULSON AR: DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74:5463-5467, 1977
39. KANAME S, UCHIDA S, OGATA E, KUROKAWA K: Autocrine secretion of transforming growth factor-β in cultured rat mesangial cells. Kidney Int 42:1319-1327, 1992
40. CHAPLEAU MW: Are arterial pressure and deformation the sole determinants of baroreceptor activity? Importance of humoral and endothelial modulation in normal and disease states. Hypertension 19:278-280, 1992
41. SAKURAI T, YANAGISAWA M, MASAKI T: Molecular characterization of endothelin receptors. Trends Pharmacol Sci 13:103-108, 1992
42. VON LINDERN M, VAN BAAL S, WIEGANT J, RAAP A, HAGEMEIJER A, GROSVELD G: can, a putative oncogene associated with myeloid leukemogenesis, may be activated by fusion of its 3′ half to different genes: Characterization of the set gene. Mol Cell Biol 12:3346-3355, 1992
43. FAJARDO LF, KWAN HH, KOWALSKI J, PRIONAS SD, ALLISON AC: Dual role of tumor necrosis factor-α in angiogenesis. Am J Pathol 140:539-544, 1992
44. ROBERTS AB, ANZANO MA, LAMB LC, SMITH JM, SPORN MB: New class of transforming growth factors potentiated by epidermal growth factor: Isolation from non-neoplastic tissues. Proc Natl Acad Sci USA 78:5339-5343, 1981
45. MORALES TI: Transforming growth factor-α1 stimulates synthesis of proteoglycan aggregates in calf articular cartilage organ cultures. Arch Biochem Biophys 286:99-106, 1991
46. NAKAMURA T, MILLER D, RUOSLAHTI E, BORDER WA: Production of extracellular matrix by glomerular epithelial cells is regulated by transforming growth factor-α1. Kidney Int 41:1213-1221, 1992
47. OWENS GK, GEISTERFER AAT, YANG YW-H, KOMORIYA A: Transforming growth factor-α-induced growth inhibition and cellular hypertrophy in cultured vascular smooth muscle cells. J Cell Biol 107:771-780, 1988